189 related articles for article (PubMed ID: 34036793)
1.
Riggs MJ; Sheridan SD; Rao RR
Stem Cells Dev; 2021 Jul; 30(14):705-713. PubMed ID: 34036793
[TBL] [Abstract][Full Text] [Related]
2. Standardization of Cell Culture Conditions and Routine Genomic Screening under a Quality Management System Leads to Reduced Genomic Instability in hPSCs.
Molina-Ruiz FJ; Introna C; Bombau G; Galofre M; Canals JM
Cells; 2022 Jun; 11(13):. PubMed ID: 35805069
[TBL] [Abstract][Full Text] [Related]
3. The safety of human pluripotent stem cells in clinical treatment.
Simonson OE; Domogatskaya A; Volchkov P; Rodin S
Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
[TBL] [Abstract][Full Text] [Related]
4. Assessing Cell Competition in Human Pluripotent Stem Cell (hPSC) Cultures.
Price CJ; Barbaric I
Curr Protoc; 2022 May; 2(5):e435. PubMed ID: 35621694
[TBL] [Abstract][Full Text] [Related]
5. Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.
Kropp C; Kempf H; Halloin C; Robles-Diaz D; Franke A; Scheper T; Kinast K; Knorpp T; Joos TO; Haverich A; Martin U; Zweigerdt R; Olmer R
Stem Cells Transl Med; 2016 Oct; 5(10):1289-1301. PubMed ID: 27369897
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
Meng G; Liu S; Rancourt DE
Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
[TBL] [Abstract][Full Text] [Related]
7. Culturing human pluripotent stem cells for regenerative medicine.
Ozawa H; Matsumoto T; Nakagawa M
Expert Opin Biol Ther; 2023; 23(6):479-489. PubMed ID: 37345510
[TBL] [Abstract][Full Text] [Related]
8. Exploring the effects of cell seeding density on the differentiation of human pluripotent stem cells to brain microvascular endothelial cells.
Wilson HK; Canfield SG; Hjortness MK; Palecek SP; Shusta EV
Fluids Barriers CNS; 2015 May; 12():13. PubMed ID: 25994964
[TBL] [Abstract][Full Text] [Related]
9. Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes.
Takenaka C; Miyajima H; Yoda Y; Imazato H; Yamamoto T; Gomi S; Ohshima Y; Kagawa K; Sasaki T; Kawamata S
PLoS One; 2015; 10(6):e0129855. PubMed ID: 26115194
[TBL] [Abstract][Full Text] [Related]
10. Detecting Genetic Mosaicism in Cultures of Human Pluripotent Stem Cells.
Baker D; Hirst AJ; Gokhale PJ; Juarez MA; Williams S; Wheeler M; Bean K; Allison TF; Moore HD; Andrews PW; Barbaric I
Stem Cell Reports; 2016 Nov; 7(5):998-1012. PubMed ID: 27829140
[TBL] [Abstract][Full Text] [Related]
11. Modeling the selective growth advantage of genetically variant human pluripotent stem cells to identify opportunities for manufacturing process control.
Beltran-Rendon C; Price CJ; Glen K; Stacey A; Barbaric I; Thomas RJ
Cytotherapy; 2024 Apr; 26(4):383-392. PubMed ID: 38349312
[TBL] [Abstract][Full Text] [Related]
12. Alternative cultures for human pluripotent stem cell production, maintenance, and genetic analysis.
Chen KG; Hamilton RS; Robey PG; Mallon BS
J Vis Exp; 2014 Jul; (89):. PubMed ID: 25077932
[TBL] [Abstract][Full Text] [Related]
13. Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates.
Abraham S; Sheridan SD; Miller B; Rao RR
Biotechnol Prog; 2010; 26(4):1126-34. PubMed ID: 20730767
[TBL] [Abstract][Full Text] [Related]
14. Engineered peptide modified hydrogel platform for propagation of human pluripotent stem cells.
Richardson T; Wiegand C; Adisa F; Ravikumar K; Candiello J; Kumta P; Banerjee I
Acta Biomater; 2020 Sep; 113():228-239. PubMed ID: 32603868
[TBL] [Abstract][Full Text] [Related]
15. Female human pluripotent stem cells rapidly lose X chromosome inactivation marks and progress to a skewed methylation pattern during culture.
Geens M; Seriola A; Barbé L; Santalo J; Veiga A; Dée K; Van Haute L; Sermon K; Spits C
Mol Hum Reprod; 2016 Apr; 22(4):285-98. PubMed ID: 26786180
[TBL] [Abstract][Full Text] [Related]
16. Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells.
Amit M; Laevsky I; Miropolsky Y; Shariki K; Peri M; Itskovitz-Eldor J
Nat Protoc; 2011 May; 6(5):572-9. PubMed ID: 21527915
[TBL] [Abstract][Full Text] [Related]
17. Methods for Automated Single Cell Isolation and Sub-Cloning of Human Pluripotent Stem Cells.
Vallone VF; Telugu NS; Fischer I; Miller D; Schommer S; Diecke S; Stachelscheid H
Curr Protoc Stem Cell Biol; 2020 Dec; 55(1):e123. PubMed ID: 32956572
[TBL] [Abstract][Full Text] [Related]
18. Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells.
Ben-David U; Arad G; Weissbein U; Mandefro B; Maimon A; Golan-Lev T; Narwani K; Clark AT; Andrews PW; Benvenisty N; Carlos Biancotti J
Nat Commun; 2014 Sep; 5():4825. PubMed ID: 25198699
[TBL] [Abstract][Full Text] [Related]
19. Clump-passaging-based efficient 3D culture of human pluripotent stem cells under chemically defined conditions.
Lee MO; Jeon H; Son MY; Lee SC; Cho YS
Biochem Biophys Res Commun; 2017 Nov; 493(1):723-730. PubMed ID: 28859981
[TBL] [Abstract][Full Text] [Related]
20. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
